Alpha 2.0
Login Register
» Articles » PMID: 11203727

Orlistat Associated with Hypertension. Digit Preference Lays Conclusions About Orlistat Open to Doubt

Overview
Journal BMJ
Specialty General Medicine
Date 2001 Feb 24
PMID 11203727
Citations 1
Authors
G D Johnston
Affiliations
Soon will be listed here.
Citing Articles

Orlistat-associated adverse effects and drug interactions: a critical review.

Filippatos T, Derdemezis C, Gazi I, Nakou E, Mikhailidis D, Elisaf M Drug Saf. 2007; 31(1):53-65.

PMID: 18095746 DOI: 10.2165/00002018-200831010-00005.

References
1.
Davidson M, Hauptman J, DIGIROLAMO M, Foreyt J, Halsted C, Heber D . Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999; 281(3):235-42. DOI: 10.1001/jama.281.3.235. View
2.
Zavoral J . Treatment with orlistat reduces cardiovascular risk in obese patients. J Hypertens. 1999; 16(12 Pt 2):2013-7. DOI: 10.1097/00004872-199816121-00024. View
3.
Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J . Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999; 13(9):569-92. DOI: 10.1038/sj.jhh.1000917. View
4.
Mulrow C, Chiquette E, Angel L, Cornell J, Summerbell C, Anagnostelis B . Dieting to reduce body weight for controlling hypertension in adults. Cochrane Database Syst Rev. 2000; (2):CD000484. DOI: 10.1002/14651858.CD000484. View
5.
Persson M, Vitols S, Yue Q . Orlistat associated with hypertension. BMJ. 2000; 321(7253):87. PMC: 27428. View